Keywords: barr, plan, approved, over, otc, sale, fda
Barr's Plan B approved for over 18 OTC sale by FDA after three-year battle
Article | 04 September 2006
The US Food and Drug Administration has granted over-the-counter marketing permission for New Jersey-based drugmaker Barr Pharmaceuticals' Plan B (levonorgestrel) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
